Biomedical Engineering Reference
In-Depth Information
for a USP chapter with clinically relevant test methods. Pharm Forum 37(4).
http://www.usppf.
61. Bisgaard H, Anhøj J, Wildhaber JH (2000) Spacer devices. In: Bisgaard H, O'Callaghan C,
Smaldone GC (eds) Drug delivery to the lung. Marcel Dekker, NY, pp 389-420
62. Canadian Standards Association (CSA) (2008) Spacers and holding chambers for use with
metered-dose inhalers, CAN/CSA/Z264.1-02, Mississauga, ON, Canada.
http://shop.csa.ca/
1 Sept 2011
63. Landahl HD (1963) Note on the removal of airborne particles by the human respiratory tract
with particular reference to the role of diffusion. Bull Math Biophys 25:29-39
64. Kwok PCL, Chan H-K (2007) Electrostatic charge in pharmaceutical systems. In: Swarbrink J
(ed) Encyclopedia of pharmaceutical technology, 3rd edn. Informa Healthcare, NY,
pp 1535-1548
65. Hendricks CD (1973) Charging macroscopic particles. In: Moore AD (ed) Electrostatics and
its applications. John Wiley & Sons, NY, pp 57-85
66. O'Leary M, Balachandran W, Chambers F (2008) Nebulised aerosol electrostatic charge
explored using bipolar electrical mobility profiles. In: Industry Appl. IEEE-IAS Annual
Meeting, Edmonton, AB, Canada, pp. 1-5.
http://ieeexplore.ieee.org/xpl/freeabs_all.
jsp?arnumber=4658914
. Accessed 6 Jan 2012
67. Beleca R, Abbod M, Balachandran W, Miller PR (2010) Investigation of electrostatic proper-
ties of pharmaceutical powders using phase Doppler anemometry. IEEE Trans Ind Appl
46(3):1181-1187
68. Kulon J, Balachandran W (2001) The measurement of bipolar charge on aerosols. J Electrostat
51-52:552-557
69. Glover W, Chan H-K (2004) Electrostatic charge characterization of pharmaceutical aerosols
using electrical low-pressure impaction (ELPI). J Aerosol Sci 35(6):755-764
70. Peart J, Magyar C, Byron PR (1998) Aerosol electrostatics: metered-dose inhalers (MDIs). In:
Dalby RN, Byron PR, Farr SJ (eds) Respiratory drug delivery-VI. Interpharm, Buffalo Grove,
IL, pp 227-233
71. Piérart F, Wildhaber JH, Vrancken I, Devadason SG, Le Souëf PN (1999) Washing plastic
spacers in household detergent reduces electrostatic charge and greatly improves delivery. Eur
Respir J 13(3):673-678
72. Martin AR, Finlay WH (2012) Aerosol drug delivery to the lungs. In: Gad SC (ed) Development
of therapeutic agents handbook. John Wiley & Sons, NY, pp 565-588
73. Smyth H, Brace G, Barbour T, Gallion J, Grove J, Hickey AJ (2006) Spray pattern analysis for
metered dose inhalers: effect of actuator design. Pharm Res 23(7):1951-1956
74. Myrdal P, Stein S, Mogalian E, Hoye W, Gupta A (2004) Comparison of the TSI model 3306
impactor inlet with the Andersen cascade impactor: solution metered dose inhalers. Drug Dev
Ind Pharm 30(8):859-868
75. Rao N, Kadrichu N, Ament B (2010) Application of a droplet evaporation model to aerody-
namic size measurement of drug aerosols generated by a vibrating mesh nebulizer. J Aerosol
Med Pulm Drug Deliv 23(5):295-302
76. Copley M, Smurthwaite M, Roberts DL, Mitchell JP (2005) Revised internal volumes of cas-
cade impactors for those provided by Mitchell and Nagel. J Aerosol Med 18(3):364-366
77. Primiano FP, Saidel GM, Montague FW, Kruse KL, Green CG, Horowitz JG (1988) Water
vapour and temperature dynamics in the upper airways of normal and CF subjects. Eur Respir
J 1(5):407-414
78. Telko MJ, Hickey AJ (2005) Dry powder inhaler formulation. Respir Care 50(9):1209-1227
79. Dunbar CA, Hickey AJ, Holzner P (1998) Dispersion and characterization of pharmaceutical
dry powder aerosols. Kona Powder Part J 16:7-44
80. Hindle M, Makinen GM (1996) Effects of humidity on the
in-vitro
aerosol performance and
aerodynamic size distribution of cromolyn sodium for inhalation. Eur J Pharm Sci 4S1:142S
81. United States Pharmacopeial Convention (2012) USP 35-NF 30 Chapter 1601: products for
nebulization. United States Pharmacopeial Convention, Rockville, MD
Search WWH ::
Custom Search